• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    Provider Advisories

    ​​Medicaid Corona​virus Disease 2019 (COVID-19) Updates​
    During this rapid​ly evolving situation, we will provide updates as they become available. All Medicaid Providers should check the Medicaid COVID-19 Provider Updates page often for updates. For general coronavirus information, visit coronavirus.maryland.gov​​​
    ​2022 ​ ​ ​​
    Date Nu​mber Subject Targeted Provider
    January 26, 2022
    ​2021 ​ ​ ​​
    Date Nu​mber Subject Targeted Provider
    ​December 16, 2021
    ​Pharmacists, Physicians and Pharmacies​​
    ​December 14, 2021
    Maryland Medicaid’s Preferred Drug List (PDL) – January 1, 2022
    ​Pharmacists, Physicians and Pharmacies​

    ​December 10, 2021
    ​Pharmacists, Physicians and Pharmacies​
    ​​December 10, 2021

    ​Pharmacists, Physicians and Pharmacies​
    ​November 17
    Update of Nutritional Prior Authorization (DHMH 3495) Form​
    ​​Pharmacists, Physicians and Pharmacies​
    ​November 15
    Updated Hepatitis C Prior Authorization Form​
    ​Pharmacists, Physicians and Pharmacies
    ​October 4
    Concurrent use of Opioids and Medication Assisted Treatment (MAT)
    ​Pharmacists, Physicians and Pharmacies
    ​September 1
    ​Pharmacy Provider Guidance on COVID-19 Additional Vaccine ​​Dose
    ​Pharmacists and Pharmacies
    August 4
    ​Resumption of COVID-19 Emergency Activity Prior Authorization Requirements
    Pharmacists and Pharmacies
    July 12​
    229 MDH Office of Pharmacy Services Call Center Helpline Return to Live Call OperationsPharmacists and Pharmacies
    June 23228
    Elimination of S​ignature-less Deliveries of PharmaceuticalsPharmacists and Pharmacies
    June 18227
    Maryland's Preferred Drug List effective 7-1-21Pharmacists, Physicians and Pharmacies
    April 21226 Changes to DAW6 Drug ProgramPharmacists and Pharmacies
    April 20225 Opioid Naive ParticipantsPharmacists and Pharmacies
    March 23224 COVID-19 Vaccine Incentive Fee Increase - UPDATEPharmacists and Pharmacies
    January 29223 Nutritional SupplementsPharmacists and Pharmacies
    January 27222 Updated Professional Dispensing feesPharmacists and Pharmacies
    January 12221 Updated Pharmacy Provider GuidancePharmacists and Pharmacies
      ​ ​ ​
    2020 ​ ​ ​
    Date Number Subject Targeted Provider
    December 18220 Maryland's Preferred Drug List effective 1-1-2021Pharmacists, Pharmacies and Physicians
    December 11219 Pharmacy Provider Guidance on COVID-19 Vaccines AdministrationPharmacists and Pharmacies
    November 17218 Brand Bethkis is Preferred on PDL.Pharmacists and Pharmacies
    October 20217 Pharmacy Provider Guidance on VaccinesPharmacists and Pharmacies
    September 22216 Quantity Prescribed Field Required for Schedule II DrugsPharmacists, Pharmacies and Physicians
    August 10215 Testing for COVID-19 by Medicaid Pharmacies - Follow-up Guidance (updated)Pharmacists and Pharmacies
    June 17214 Maryland's Preferred Drug List 7-1-20Pharmacists, Pharmacies and Physicians
    June 10213 Testing for COVID-19 by Medicaid Pharmacies - Follow-up GuidancePharmacists and Pharmacies
    May 29212 Testing for COVID-19 by Medicaid PharmaciesPharmacists and Pharmacies
    April 22211 MDH Office of Pharmacy Services Call Center Helpline Changes to Voicemail SystemPharmacists, Pharmacies, Physicians and Consumers
    April 7210 14-day supply emergency overridePharmacists and Pharmacies
    April 3209 Signature-less Deliveries of Pharmaceuticals - Follow-up GuidancePharmacists and Pharmacies
    April 1208 Signature-less Deliveries of PharmaceuticalsPharmacists and Pharmacies
    March 27207 14-day emergency supplyPharmacists and Pharmacies
    March 12206 Waiving Early Refill EditsPharmacists, Pharmacies and Physicians
    February 13205 Removal of Adderall XR from DAW6Pharmacists and Pharmacies
     ​ ​ ​ ​
    2019 ​ ​ ​
    Date Number Subject Targeted Provider
    December 13204 Preferred Drug List 1.1.2020Pharmacists, Pharmacies and Physicians
    December 10203 Lyrica Capsules Removal from DAW6Pharmacists and Pharmacies
    December 5202 Carve-In of HIV-AIDS Medications to MCOPharmacists, Pharmacies and Providers
    November 14201 Hepatitis C CE SeminarProviders and Pharmacists
    October 23200 Lyrica Oral solution Removal from DAW6Pharmacists and Pharmacies
    July 26199 RevatioPharmacists and Pharmacies
    July 26198 Brand Lyrica is PreferredPharmacists and Pharmacies
    June 19197 Maryland's Preferred Drug ListPharmacists, Pharmacies and Physicians
    April 5196 Brand vs Generic DAW 6 changesPharmacists and Pharmacies
    March 4195 Suboxone Film now preferredPharmacists and Pharmacies
    February 14194 Brand vs Generic DAW 6 changesPharmacists and Pharmacies
    January 24193 Kapvay ER Removal from DAW6. 1.28.19Pharmacists and Pharmacies
    January 23192 Reyataz Removal from DAW6. 2.15.19Pharmacists and Pharmacies
      ​ ​ ​
    2018 ​ ​ ​
    Date Number Subject Targeted Provider
    December 19191 PDL Maryland's Preferred Drug ListPharmacies, Pharmacists and Physicians
    December 12190 Carve Out of Spinraza and CinryzePharmacies and Pharmacists
    October 3189 Diastat Removal from DAW 6 ProgramPharmacies, Pharmacists and Physicians
    September 20188 Carve Out of LucemyraPharmacies and Pharmacists
    August 3187 Long Term Care Eligibility for Medicaid RecipientsPharmacies and Pharmacists
    June 29186 DAW6 Suboxone FilmPharmacies and Pharmacists
    June 27185 Preferred Drug List 7.1.18Pharmacists, Pharmacies and Consumers
    April 24184 Removal of Brand InvegaPharmacists and Pharmacies
    April 17183 Norvir and ReyatazPharmacists and Pharmacies
    April 16182 Changes DAW6Pharmacists and Pharmacies
    February 13181 Tamiflu and it's generic Change on the PDLPharmacists and Pharmacies
    February 2180 Change in Online Preferred drug ListPharmacists, Pharmacies and Consumers
      ​ ​ ​
    ​2017 ​ ​ ​
    Date Number Subject Targeted Provider
    December 20179 Preferred Drug List 1.1.18Pharmacists, Pharmacies and Consumers
    December 13178 Sabril Powder PacketPharmacy, Pharmacists and Physicians
    December 5177
    Carve-out of IngrezzaPharmacy, Pharmacists and Physicians
    June 22176 Maryland Preferred Drug List 7. 1 .17Pharmacists, Pharmacies and Consumers
    June 16
    175 Changes in the Opiate ClassPharmacists , Pharmacies and Consumers
    May 12174 Brand Metadate CD Removal from DAW 6 ProgramPharmacists and Pharmacies
    April 5173 FSS and Nominal Price UpdatePharmacists and Pharmacies
    March 30172 Change in Pharmacy Reimbursement MethodologyPharmacists and Pharmacies
    March 29171 (correction) Removal of Brand Seroquel XR DAW6Pharmacists and Pharmacies
    March 13171 Removal of Brand Seroquel XR DAW6Pharmacists and Pharmacies
      ​ ​ ​
    2016 ​ ​ ​
    Date Number  Subject Targeted Provider
    December 21170 Maryland's Preferred Drug List 1 1 17Pharmacists, Pharmacies and Consumers
    November 18169 Seroquel XR DAW6Pharmacists and Pharmacies
    October 26168 Generic vs Brand ChangesPharmacists and Pharmacies
    October 19167 Copay for Tobacco Cessation ProductsPharmacists, Pharmacies and Consumers
    June 14166 PDL as of 7/ 1/ 16Pharmacists, Pharmacies and Consumers
    June 1165 Zubsolv Preferred 6.1.16Pharmacists and Pharmacies
    May 3164 Gleevac® (Brand) tablets Is to Be Dispensed Over Its GenericPharmacists and Pharmacies
    April 26163 Nasonex® Nasal Spray 50 mcg Is Preferred (DAW6) Over Its GenericPharmacists and Pharmacies
    March 3162 Advisory 162 BrandsPharmacists and Pharmacies
      ​ ​ ​
    ​2015 ​ ​ ​
    Date Number Subject Targeted Provider
    December 17161 PDL as of 1/1/2016Pharmacists, Pharmacies and Consumers
    December 1160 Brand AbilifyPharmacists and Pharmacies
    November 20159 Invega Tablets on DAW 6 ProgramPharmacists and Pharmacies
    September 30158 Clozapine update_ REMSPharmacists and Pharmacies
    July 9157 Copaxone 20mg DAW6. Pharmacists and Pharmacies
    June 22156 PDL as of 7/1/2015Pharmacists, Pharmacies and Consumers
    May 12155 Generic vs BrandPharmacists and Pharmacies
    March 13154 Quantity LimitsPharmacists, Pharmacies, Physicians and Consumers
      ​ ​ ​
    2014 ​ ​ ​
    Date Number Subject Targeted Provider
    December 19153 PDL as of 1/1/2015
    Pharmacists, Pharmacies and Consumers
    December 11152 Intuniv DAW 6Pharmacists, Pharmacies, Physicians and Consumers
    December 11151 Carve Out of Substance Use Disorder Medications and SuboxonePrescribers
    December 5150 Carve-Out of Substance Use Disorder MedicationsPharmacists and Pharmacies
    October 10149 How to prescribe NaloxonePrescribers
    September 12148 Carve-Out of NaloxonePharmacists and Pharmacies
    July 30147 Tramadol as a Controlled SubstancePharmacists, Physicians and Pharmacies
    July 9146 Changes in DAW 6 programPharmacists, Physicians and Pharmacies
    June 17145 PDL as of 07/01/14Pharmacists, Physicians and Consumers
    June 10144 Quantity LimitsPharmacists, Pharmacies, Physicians and Consumers
    April 23143 Autorefill and return to stockPharmacists and Pharmacies
    April 11142 QL UpdatePharmacists, Physicians and Consumers
      ​ ​ ​
    2013 ​ ​ ​
    DateNumberSubjectTargeted Provider
    December 26141 MD PDLPharmacists, Physicians and Consumers
    December 19140 CymbaltaPharmacists and Pharmacies
    December 5139 OTC Plan B no age limitPharmacists and Pharmacies
    October 25138 Update on MADAP ProgramPharmacists and Pharmacies
    October 24137 Extended OutagePharmacists and Pharmacies
    October 15136 PAC programPharmacists and Pharmacies
    October 9135 Brand name LidodermPharmacists and Pharmacies
    July 24134 Peer Review Program Expansion 0 to 17Pharmacists, Pharmacies and Physicians
    July 12133 Some Brands Preferred over generics July 2013Pharmacists, Pharmacies and Physicians
    July 1132 MD PDL 7.1.13Pharmacists, Physicians and Consumers
    May 29131 Some Brands Preferred over generics June 2013Pharmacists and Pharmacies
    April 1130 72 hours emergency supplyPharmacists and Pharmacies
    January 8129 Openings on P&T CommitteePharmacists, Physicians and Consumers
     ​ ​ ​ ​
    2012 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 28128 Preferred Drug List UpdatePharmacies
    December 20127 Drug Coverage Changes for Full DualsPharmacies
    December 17126 Update on New Operating System for MMPPPharmacies
    December 11125 Holiday Payment SchedulePharmacies
    November 27124 Metadate CD Becomes a Preferred Brand in MedicaidPharmacies
    November 7123 Some Brands Preferred over generics Nov. 2012Pharmacies
    November 7122 No PA Required for Tier 2 Abilify for ages 10-17Prescribers
    October 11121 Ovide Will No Longer Be Brand PreferredPharmacies
    October 4120 New Operating System for MMPPPharmacies
    September 19119 Geodon Will No Longer Be Brand preferredPharmacies
    September 18118 Lexapro Will No Longer Be Brand PreferredPharmacies
    September 14117 Prior Authorization for Tier 2 and Non-preferred Antipsychotic DrugsPharmacies and Prescribers
    August 7116 New Web Address for Pharmacy ProgramPharmacies and Prescribers
    July 20115 Peer Review Programs Expanded to Include Children up to Age 10
    Pharmacies and Prescribers
    July 3114 Changes in Preferred Brands vs Generics: Kadian and RoxicodonePharmacies
    June 27113 Preferred Drug List July 1, 2012Prescribers and Pharmacies
    June 8112 Updates to List of Brand Drugs Preferred vs Generics on the Maryland Medicaid PreferredPharmacies and Prescribers
    May 30111 Lipitor No Longer Brand Preferred on Maryland Medicaid Preferred Drug ListPrescribers and Pharmacies
    April 25110 Medicaid Prefers Brands Lexapro and GeodonPharmacies and Prescribers
    February 3109 Medicaid Temporarily Authorizes Brand Prevacid SolutabsPrescribers and Pharmacies
    January 4108 Late Refills for HIV Drugs - AgainPharmacies
      ​ ​ ​
    2011 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 29107 Preferred Drug List UpdatePharmacies and Prescribers
    December 29106 Cost of Dispensing AnalysisPharmacies
    December 21105 Holiday Payment SchedulePharmacies
    December 20104 Transition to D.0Pharmacies
    December 20103 Transition to D.0 for LTC PharmaciesPharmacies
    December 13102 Changes in Preferred Multisource Brands on PDL, Use DAW 6Prescribers and Pharmacies
    December 5101 Clarify Regulation ChangesPharmacies
    November 30100 Pharmacy Services Regulation ChangesPharmacies
    November 499 Late Refills for HIV/AIDS MedicationsPharmacies and Prescribers
    October 798 Peer Review Program for AntipsychoticsPharmacies and Prescribers
    June 3097 Preferred Drug List Updat​e
    Pharmacies and Prescribers
    June 2996 Dispensing Fee Changes
    All Pharmacies
    June 2895 Preferred Brands on the PDL, Use DAW 6Pharmacies and Prescribers
    June 2794 Corrective Managed Care Programs and Misuse of Controlled SubstancesPharmacies
    June 2393 Quantity Limits and Dose OptimizationPhysicians and Pharmacies
    May 1392 OIG AuditsPharmacies
    May 1391 List of Preferred Multisource Brands Has ChangedPrescribers and Pharmacies
    April 2990 Notice of Survey for Dispensing FeePharmacies
    March 2389 Kapvay for Ages 6-17 Moved to Mental Health Carve-OutPharmacies and Prescribers
    February 2588 Important Changes Related to Prior Authorization Requests for Fee-for-Service MembersPharmacies and Prescribers
      ​ ​ ​
    ​2010 ​ ​ ​
    Date Number Subjects Targeted Provider
    September 3087 Generic vs Brand on the Preferred Drug ListPrescribers and Pharmacies
    September 3086 Updated Preferred Drug List Effective October 1, 2010Prescribers and Pharmacies
    July 1985 Reminder: Tamper Resistant Prescriptions Required for Medicaid RxPrescribers and Pharmacies
    June 2884 Intuniv Moved to Mental Health Formulary for MCO Members Aged 6-17 Effective July 1, 2010Prescribers and Pharmacies
    April 1683 Limited Coverage of OTC Drugs for Dual EligiblesPrescribers and Pharmacies
    April 182 Few Exceptions to Generic SubstitutionPrescribers and Pharmacies
    March 3181 Preferred Drug List Effective April 1, 2010Prescribers and Pharmacies
    March 1380 Over the Counter Plan B CoveragePharmacies
    February 979 Rubber Stamped Prescribed Are InvalidPrescribers and Pharmacies
    January 2678 Effective handling of Claim RejectionsPharmacies
      ​ ​ ​
    ​2009 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 1877 Holiday ClosingsPharmacies and Prescribers
    October 976 Update on mass Adjustments of legend InsulinsPharmacies
    October 175 Over-the-Counter Plan B Coverage Up-DatePharmacies
    October 274 Some Multisource Brand Name Drugs Preferred Over GenericsPharmacies and Prescribers
    October 173 Preferred Drug List Effective October 1, 2009Pharmacies and Prescribers
    October 172 Changes for the Status of Antipsychotic Medication on Preferred Drug ListPrescribers
    September 3071 30-Day Emergency Supply of Atypical AntipsychoticsPharmacies
    September 2470 Mass Adjustment for Legend InsulinsPharmacies
    June 2969 Changes in Mental Health Carve OutPharmacies and Prescribers
    May 1968 New Denial Codes for Non-rebatable Drugs, DESI and Obsolete DrugsPharmacies
    April 2267 Not all Generics are PreferredPharmacies and Prescribers
    April 966 Preferred Drug List Effective April 1, 2009Pharmacies and Providers
    April 765 Maryland Medicaid May Cover up to a 30-day Emergency Supply of Atypical AntipsychoticsPharmacies
    March 2464 Time Limit Extended for Filing ClaimsPharmacies
    February 1863 Prescriber NPI Required on Pharmacy Claims, Effective March 1, 2009Prescribers
    February 1862 Claim Must Have Prescriber NPIPharmacies
      ​ ​ ​
    2008 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 2261 Pharmacy Hotline Holiday SchedulePharmacies
    December 960 Depo-medroxyprogesteronePharmacies
    December 1859 Payments Delayed One WeekPharmacies
    September 2458 30-day Emergency Supply May be Available for Atypical Antipsychotic PrescriptionsPharmacies
    September 2257 Required Tamper-resistant Pad Features Effective October 1, 2008Pharmacies
    September 2256 Required Tamper-resistant Prescription Pad Features Effective October 1, 2008Prescribers
    September 1855 Automatic Correction of Underpayments for CellCept, Lunesta, Xopenex, Fuseon kit and Travatan Z ClaimsPharmacies
    September 1254 Scheduled Down Time for Medicaid Claims Processing SystemPharmacies
    August 2053 Physician Administered MedicationsPrescribers
    July 1652 Intervention CodesPharmacies
    July 1551 Pain Management AgreementsPrescribers
    June 2550 Information about Formularies, PDL and PAs at Epocrates.com and DHMH websitePrescribers and Pharmacies
    May 249 Prescriber NPIPharmacies
    April 1148 POS System MaintenancePharmacies
    April 347 Preferred Drug List, effective April 1, 2008Prescribers and Pharmacies
    March 2646 NPI Information for PrescribersPrescribers and Pharmacies
    March 745 Tamper Resistant Prescription Pad Features to be Phased in Beginning April 1, 2008Prescribers and all Pharmacies
    February 2644 Reminder: At Least One Recognized Tamper Resistant Feature Required as of April 1, 2008 on all Written Medical PrescriptionsPrescribers and all Pharmacies
    February 1243 Temporary Technical Difficulty Processing Medstar Family Choice ClaimsAll Pharmacies
    February 642 March 1- NPI Required on ClaimsProviders
     ​ ​ ​ ​
    2007 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 2741 Atypical Antipsychotics, Zyprexa Step Therapy, AIDS/HIV Drugs Carved Out from MCOs, Refills of Controlled DrugsProviders and Prescribers
    October 140 Tamper-Resistant Prescription Pads Are Delayed Until April 1, 2008Prescribers and all Pharmacies
    August 2939 Changes to Preferred Drug ListPrescribers and all Pharmacies
    May 938 Correction of Underpayments, Over-the-Counter Plan B Coverage, Clinical Criteria for Cymbalta, Coordination of BenefitsPrescribers and all Pharmacies
    April 1237 Possible Underpayments, Unacceptable Prescriber DEA Numbers, Early Refills for Recently Discharged Long Term CarePrescribers and all Pharmacies
    March 2836 Explanations of Some Claim Rejection Messages, New EVS Inquiry Phone Number, NPI Reminder, and Changes to Preferred Drug List (PDL) effective April 2007All Pharmacies
    February 935 Late PaymentsAll Pharmacies
    February 534 New Medicaid POS Claims ProcessorAll Pharmacies
    January 2433 POS System To Be Shutdown: New Fax Numbers for PAsAll Pharmacies
    January 1732 Reminder - POS Provider TrainingAll Pharmacies
      ​ ​ ​
    Date Number Subjects Targeted Provider
    December 2131 New POS Processor; Zocor®; Prescription Transfers; Part D QuestionsAll Pharmacies
    October 530 Pharmacy Dispensing Fee SurveyAll Pharmacies
    September 2729 Changes to the Preferred Drug List; New EVS System; Narrow Therapeutic Index DrugsPrescribers and all Pharmacies
    July 2828 Brand Name PDL Anomalies Useful Medicare Part D Phone NumbersPrescribers and all Pharmacies
    June 2927 New Primary Adult CarePrescribers and all Pharmacies
    May 1126 New Primary Adult Care Program (PAC) Medicare Part D Exception and Prior Authorization Request FormPrescribers and all Pharmacies
    March 2325 Revised Preferred Drug List Transition from Pharmacy Assistance to Medicare Part DPrescribers and All Pharmacies
    March 224 Dummy DEA Numbers Medicare Pare D IssuesAll Pharmacies
    February 2223 Changes to the Preferred Drug List (PDL) Effective April 2006Prescribers and all Pharmacies
    January 1022 Useful Medicare Phone Numbers & Medicaid Coverage of Drug Classes Excluded from Medicare Part D Basic PlansAll Pharmacies
      ​ ​ ​
    2005 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 1621A Temporary Suspension of Early Refill Edits for Medicare RecipientsPrescribers
    December 1421 Temporary Suspension of Early Refill Edits for Medicare RecipientsAll Pharmacies
    November 2320 Medicare Part DPrescribers and all Pharmacies
    September 1619 Changes to the Preferred Drug List (PDL) Step Therapy for Stimulants and Related Agents Revised Quantity Limits for EmendPrescribers and all Pharmacies
    September 1218 Hurricane Katrina Evacuees and Maryland Medicaid ProgramPrescribers and all Pharmacies
    June 23 (Revised June 28)17 Revised Preferred Drug List
    Special Grandfathering for Norvasc, Coreg and Zetia
    Safety Concerns for Certain Generics
    Antimigraine (Triptan) Quantity Limits
    Prescribers and all Pharmacies
    April 2816 Claims Processing Upgrade NotesAll Pharmacies
    April 1315 Planned Claims Processing System MaintenanceAll Pharmacies
    March 114
    Further Clarification: Atypical Antipsychotic Dose Optimization Appropriate Use of Palladone Grandfathering Non-Preferred Mental Health DrugsPrescribers and all Pharmacies
      ​ ​ ​
    2004 ​ ​ ​
      ​ ​ ​
    ​2003 ​ ​ ​
    Date Number Subjects Targeted Provider
    December 124 Revised Preferred Drug List (PDL): Cumulative Update for PrescribersPrescribers
    N​ovember 33 Preferred Drug List (PDL Implementation) PDL Instructions for the PrescriberPrescribers
    October 312 Preferred Drug List (PDL Implementation) PDL Instructions for the PharmacistCommunity Pharmacies
    October 91 Change in Pharmacy Assistance Co-payCommunity Pharmacies